First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer, Coupled to Extensive Translational Studies
about
First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer, Coupled to Extensive Translational Studies
description
clinical trial
@en
klinisch onderzoek
@nl
name
First-line Treatment With Osim ...... xtensive Translational Studies
@en
type
label
First-line Treatment With Osim ...... xtensive Translational Studies
@en
prefLabel
First-line Treatment With Osim ...... xtensive Translational Studies
@en
P17
P1476
First-line Treatment With Osim ...... xtensive Translational Studies
@en
P1813
FIOL
@en
P3098
NCT03804580
P4844
P580
2018-12-01T00:00:00Z
P582
2020-10-30T00:00:00Z